Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complex

Blood

Volumn 100, Issue 2, 2002, Pages 501-508

  Vincent Jenkins, P ^a   Freas, Jan ^a   Schmidt, Kyla M ^a   Zhou, Qian ^a   Fay, Philip J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ALANINE; ARGININE; ASPARTIC ACID; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 8A; BLOOD CLOTTING FACTOR 9A; GLUTAMINE; PHENYLALANINE; PHOSPHOLIPID; SERINE; VALINE;

ANIMAL CELL; ANISOTROPY; ARTICLE; CATALYSIS; DISSOCIATION CONSTANT; ENZYME ACTIVITY; HEMOPHILIA A; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

EID: 0037100409     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2001-12-0361     Document Type: Article

References (49)

1. The coagulation cascade: Initiation, maintenance, and regulation
2. A large region (approximately equal to 95 kDa) of human factor VIII is dispensible for in vitro procoagulant activity
3. Expression of active human factor VIII from recombinant DNA clones
4. Monoclonal antibodies to porcine factor VIII coagulant and their use in the isolation of active coagulant protein
5. Isolation and characterization of human factor VIII: Molecular forms in commercial factor VIII concentrate, cryoprecipitate, and plasma
6. The size of human factor VIII heterodimers and the effects produced by thrombin
7. Proteolytic processing of human factor VIII: Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity
8. Subunit structure of thrombin-activated porcine factor VIII
9. Human factor VIIIa subunit structure: Reconstitution of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit
10. The life cycle of coagulation factor VIII in view of its structure and function
11. Surface-dependent reactions of the vitamin K-dependent enzyme complexes
12. The role of phospholipid and factor VIIIa in the activation of bovine factor X
13. The A2 subunit of factor VIIIa modulates the active site of factor IXa
14. Factor VIIIa A2 subunit residues 558-565 represent a factor IXa interactive site
15. Localization of factor IXa and factor VIIIa interactive sites
16. Activated protein C-catalyzed inactivation of human factor VIII and factor VIIIa: Identification of cleavage sites and correlation of proteolysis with cofactor activity
17. Factor IXa protects factor VIIIa from activated protein C; factor IXa inhibits activated protein C-catalyzed cleavage of factor VIIIa at Arg562
18. The factor VIII mutation database on the world wide web: The haemophilia A mutation, search, test and resource site, HAMSTeRS update (version 3.0)
19. Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside
20. Artificial substrate for the assay of factors V and VIII
21. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
22. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
23. Factor VIIIa cofactor activity shows enhanced ionic strength sensitivity in the absence of phospholipid
24. Sequence of the murine factor VIII cDNA
25. The cDNA and derived amino acid sequence of porcine factor VIII
26. The canine factor VIII cDNA and 5′ flanking sequence
27. Structure of human factor VIII
28. Cell surface heparan sulfate proteoglycans participate in factor VIII catabolism mediated by low density lipoprotein receptor-related protein
29. The factor VIII structure and mutation resource site: HAMSTeRS version 4
30. The molecular basis for cross-reacting material-positive hemophilia A due to missense mutations within the A2-domain of factor VIII
31. Binding of human factor VIII to phospholipid vesicles
32. Platelet-derived microparticles express high affinity receptors for factor VIII
33. Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine
34. Structure of the C2 domain of human factor VIII at 1.5 A resolution
35. Walsh PN High-affinity, specific factor fXa binding to platelets is mediated in part by residues 3-11
36. Identification of the phospholipid binding site in the vitamin K-dependent blood coagulation protein factor IX
37. Kinetics of coagulation factor X activation by plateletbound factor IXa
38. Activation of the factor VIIIa-factor IXa enzyme complex of blood coagulation by membranes containing phosphatidyl-L-serine
39. Interaction of factor IXa with factor VIIIa: Effects of protease domain Ca2+ binding site, proteolysis in the autolysis loop, phospholipid, and factor X
40. The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX
41. Factor IXa:factor VIIIa interaction: Helix 330-338 of factor ixa interacts with residues 558-565 and spatially adjacent regions of the a2 subunit of factor VIIIa
42. Inhibition of human factor VIIIa by anti-A2 subunit antibodies
43. Identification of a binding site for blood coagulation factor IXa on the light chain of human factor VIII
44. Factor VIII-factor IX interactions: Molecular sites involved in enzyme-cofactor complex assembly
45. Protease and EGF1 domains of factor IXa play distinct roles in binding to factor VIIIa: Importance of helix 330 (helix 162 in chymotrypsin) of protease domain of factor IXa in its interaction with factor VIIIa
46. Regions 301-303 and 333-339 in the catalytic domain of blood coagulation factor IX are factor VIII-interactive sites involved in stimulation of enzyme activity
47. Mutation at either Arg336 or Arg562 in factor VIII is insufficient for complete resistance to activated protein C (APC)-mediated inactivation: Implications for the APC resistance test
48. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis
49. A molecular model for the triplicated A domains of human factor VIII based on the crystal structure of human ceruloplasmin